B-BIC: Translating Discoveries Into Products

connecting

A road map to commercialization

funding

Grant funding up to $350,000 per project

built

Built with 16 institutions and the NIH

weare

Boston Biomedical Innovation Center (B-BIC) is a life sciences accelerator funded by the National Institutes of Health and our member institutions to increase the return on investment in research. We speed the translation of research technologies into products for doctors and their patients, for the good of society.

Our members are a consortium of academic medical centers in Boston including Brigham and Women’s Hospital, Harvard Medical School, Massachusetts General Hospital, and the Massachusetts Institute of Technology.

grant-funding
coaching
project-mgmt
skills-dev
ext-partners
Grant Funding

B-BIC provides funding for technology development and translational research, including regulatory, reimbursement, and business development aspects that are part of an overall commercialization strategy.

Coaching
Project Management
Skills Development
External Partnerships

Clinical Domains

Heart
Lung
Blood
Sleep

Technical Domains

Device
Diagnostic
Therapeutic

New Award: Congratulations Dr. Aaron Grant!!

February 11, 2020

TITLE: Technology for Functional and Metabolic Imaging with Hyperpolarized MRI TYPE OF AWARD: Pilot CLINICAL AREA:  Heart INSTITUTION:  Beth Israel Deaconess Medical Center DESCRIPTION: MRI provides a wealth of anatomical information, but its ability to assess functional parameters such as blood flow (perfusion) and metabolism is limited by its low sensitivity and the limited range of available contrast…

Read More

How To Identify The Right Inflection Points

February 11, 2020

Contributed by Erin McKenna, Deputy Director of B-BIC & Paul Tessier, B-BIC Coach Once you understand the unmet clinical need your technology can address and have connected that need with a solid business opportunity, the next thing to be considered is to understand the development path for the product you want to create. Outlining the…

Read More

New Award: Congratulations Suneet Agarwal, MD, PhD!

January 13, 2020

TITLE: Novel Small Molecule Therapeutics for Genetic Lung and Blood Diseases TYPE OF AWARD: Drive CLINICAL AREA:  Small Molecule INSTITUTION: Boston Children’s Hospital DESCRIPTION: Telomere diseases encompass a spectrum of rare and fatal syndromes that are caused by mutations in genes regulating telomere biology. These include the severe childhood blood disorder dyskeratosis congenita (DC) and later-onset diseases such as…

Read More

New Award: Congratulations Bradley Maron, MD!

January 13, 2020

TITLE: NEDD9 Monoclonal Antibody Therapeutic for Pulmonary Thromboembolic Disease TYPE OF AWARD: Drive CLINICAL AREA:  Biologic INSTITUTION: Brigham and Women’s Hospital DESCRIPTION: Increased platelet-endothelial adhesion is a central pathobiological event underlying the pathogenesis of pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH). Current therapies to treat thrombosis in PAH and CTEPH emphasize non-specific coagulation proteins, and are associated…

Read More

Does Your Great Idea Have A Great Market Opportunity?

January 13, 2020

Contributed by Ilsa Webeck B-BIC Skills Development Expert Developing Innovative Strategies for Leading Edge Medical Technology Companies “I have an idea. A great idea. I mean, it’s an “I can’t believe no one has thought of this before” idea. The market for this product is going to be enormous.”  In conversations with innovators spanning devices, biologics,…

Read More

Unmet Clinical Need

November 14, 2019

Written by Paul Tessier A common refrain heard by healthcare entrepreneurs is that they should focus on satisfying an “unmet clinical need,” however there is no universal definition of the phrase, “unmet clinical need.”  Even established companies and public healthcare agencies, who use the concept of an unmet clinical need to assist in developing product…

Read More

B-BIC: ‘IS MORE THAN JUST FUNDING’, with Kantum Pharma

October 14, 2019

We are thrilled to share with you a new web video we are releasing that highlights our ‘Commercialization Coaches’ and other services that are ways B-BIC successfully differentiates from other grants. Kantum Pharma, dedicated to the prevention and treatment of Acute Kidney Injury, received its first B-BIC Pilot grant in 2017.

Read More

Specialist Series: Technology in Search of an Application

October 9, 2019

Technology in Search of an Application Part II of the Specialist Series: The Road to Commercialization: Challenges and Opportunities Written by John Randle Development models always start with addressing clinical needs, but scientific discoveries and technological advances typically happen independently from solving clinical problems. This article will explore ways you can ensure that you are…

Read More

FAST PITCH FOR FUNDING: FAQ

February 5, 2018

Q:  Do I need to have slides?  A:  Pitches only need to address the suggested elements.  Use of reference materials or other visual elements is welcome if they help convey the product concept and can be shared using your laptop screen.  AV equipment will not be available. Q:  How formal will the pitches be? A:…

Read More

FAST PITCH FOR FUNDING: Quick Tips for a successful pitch

August 14, 2018

Keep pitch short and focused on the technology and its commercial application. Limit the discussion of preliminary results, and focus on the most relevant results with conclusions – not data. Present the science within the context of the business strategy. This event will provide you with the opportunity to pitch a team of experts on your research.…

Read More

The Road to Commercialization: Series Introduction

September 2, 2019

Written by Erin McKenna, B-BIC Deputy Director There are multiple frameworks out there that outline the process for developing promising biomedical research into a range of innovative solutions – pharmaceuticals, biologics, medical devices, and diagnostics.  Many of these processes leverage concepts that come from regulations developed by the FDA, the European Commission and others to…

Read More

NEW AWARD: Congratulations Dr. Steven Greenberg!!

September 2, 2019

TITLE: Generation of a Novel Therapeutic Antibody for Treatment of Allergic Asthma TYPE OF AWARD: Pilot CLINICAL AREA:  Lung INSTITUTION: Brigham and Women’s Hospital   DESCRIPTION: Asthma affects 8% of the US population, approximately 25 million people. About 10% of patients have severe asthma, accounting for an estimated 1.8 million emergency department visits, 439,000 hospitalizations, and 3,630 deaths annually…

Read More

The Breakdown of a B-BIC Proposal / Business Plan

September 2, 2019

Over the course of 2019, our coaches and staff broke down the B-BIC application process to provide you with expert advice on all the of the questions we ask you to answer when applying for our program. For those who are not applying yet, the B-BIC proposal has many similarities to a business plan, which…

Read More

Congratulations Dr. Sylvie Breton!

May 27, 2019

TITLE: Diagnostic for Acute Kidney Injury Associated with Cardiovascular Diseases TYPE OF AWARD: Drive TECHNOLOGY TYPE:  Diagnostic INSTITUTION: MGH   DESCRIPTION:  Acute kidney injury (AKI) is a frequent complication in hospitalized patients, including those undergoing cardiac surgery. However, two critical barriers to the clinical management of these critically ill patients remain the need for better methods…

Read More

New Award: Congratulations Dr. Robert Flaumenhaft!

May 27, 2019

TITLE: A Rapid, Inexpensive Platelet Function Test TYPE OF AWARD: Pilot CLINICAL AREA:  Blood INSTITUTION: BIDMC DESCRIPTION:  Antiplatelet agents such as clopidogrel and aspirin are used in the treatment of heart attacks and strokes and are among the most commonly used drugs in the U.S. Problems associated with these drugs include bleeding risk (which complicates invasive…

Read More